{"id":727329,"date":"2023-01-31T16:04:44","date_gmt":"2023-01-31T21:04:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/"},"modified":"2023-01-31T16:04:44","modified_gmt":"2023-01-31T21:04:44","slug":"regeneron-announces-investor-conference-presentations-11","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/","title":{"rendered":"Regeneron Announces Investor Conference Presentations"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"start\">TARRYTON, N.Y., Jan.  31, 2023  (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: <strong>REGN<\/strong>) will webcast management participation as follows:<\/p>\n<ul>\n<li>SVB Securities Global Biopharma Conference at 9:20 a.m. ET on Tuesday, <br \/> February 14, 2023\n<\/li>\n<li>Cowen 43<sup>rd<\/sup> Annual Health Care Conference at 12:50 p.m. ET on Monday, <br \/> March 6, 2023\n<\/li>\n<li>Oppenheimer 33<sup>rd<\/sup> Annual Healthcare Conference at 9:20 a.m. ET on Monday, <br \/> March 13, 2023\n<\/li>\n<li>Barclays Global Healthcare Conference at 9:00 a.m. ET on Wednesday, <br \/> March 15, 2023<\/li>\n<\/ul>\n<p align=\"start\">The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eHEF-kn2pVbDstCTOP30gmHF9ubBYdonnc99YL7-d9rcwVT-CA8YKyiqLvVcbiBs4me6jgD2NzGnKwU1GYSbty9fwMj4vmCAjOtxjvu5M0Mw2udREMnh-9N3Lt-u7SYYdvEeQmRX3NjyV4-RtmUUkdQe_fukplBJQES0N9vx6zej_A3NhdJF5pOHmapny4py\" rel=\"nofollow noopener\" target=\"_blank\"><u>https:\/\/investor.re<\/u><u>generon.com\/events-and-presentations<\/u><\/a>. Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days.<\/p>\n<p align=\"start\">\n        <strong>About<\/strong>\u00a0<strong>Regeneron<\/strong><br \/> Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.<\/p>\n<p align=\"start\">Regeneron is accelerating and improving the traditional drug development process through our proprietary <em>VelociSuite\u00ae <\/em>technologies, such as <em>VelocImmune\u00ae<\/em>, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.<\/p>\n<p align=\"start\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NtPn8qNScP5eEV27CWB38wEfBweTbE0UYbozs-252UgXbe--c6d-si1JCvdN4UwKs7eWZUmvs1BSWwwmL95xbw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.Regeneron.com<\/u><\/a> or follow @Regeneron on Twitter.<\/p>\n<p align=\"start\">\n        <strong>Contact Information:<\/strong><br \/>\n        <br \/> Investor Relations <br \/> Ryan Crowe <br \/> 914.847.8790 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ziK2GWDh8crmpDFCEJi1dBdcDomndMWmEV9d0WNrVpIwB6Emkoy5Rmeoc_M2BkffvT410nSmWo4cgO9ndi8e2yhHmoaKUgQdUSu2p0MuZ7I=\" rel=\"nofollow noopener\" target=\"_blank\"><u>ryan.crowe@regeneron.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NWM1OTExNTItZDBjNS00Njk3LTljNGMtMDE1MjJjMDJhZTMwLTEwMTc4MjM=\/tiny\/Regeneron-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TARRYTON, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: SVB Securities Global Biopharma Conference at 9:20 a.m. ET on Tuesday, February 14, 2023 Cowen 43rd Annual Health Care Conference at 12:50 p.m. ET on Monday, March 6, 2023 Oppenheimer 33rd Annual Healthcare Conference at 9:20 a.m. ET on Monday, March 13, 2023 Barclays Global Healthcare Conference at 9:00 a.m. ET on Wednesday, March 15, 2023 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About\u00a0Regeneron Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regeneron Announces Investor Conference Presentations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727329","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regeneron Announces Investor Conference Presentations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TARRYTON, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: SVB Securities Global Biopharma Conference at 9:20 a.m. ET on Tuesday, February 14, 2023 Cowen 43rd Annual Health Care Conference at 12:50 p.m. ET on Monday, March 6, 2023 Oppenheimer 33rd Annual Healthcare Conference at 9:20 a.m. ET on Monday, March 13, 2023 Barclays Global Healthcare Conference at 9:00 a.m. ET on Wednesday, March 15, 2023 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About\u00a0Regeneron Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and &hellip; Continue reading &quot;Regeneron Announces Investor Conference Presentations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T21:04:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron Announces Investor Conference Presentations\",\"datePublished\":\"2023-01-31T21:04:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/\",\"name\":\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=\",\"datePublished\":\"2023-01-31T21:04:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-11\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron Announces Investor Conference Presentations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","og_description":"TARRYTON, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: SVB Securities Global Biopharma Conference at 9:20 a.m. ET on Tuesday, February 14, 2023 Cowen 43rd Annual Health Care Conference at 12:50 p.m. ET on Monday, March 6, 2023 Oppenheimer 33rd Annual Healthcare Conference at 9:20 a.m. ET on Monday, March 13, 2023 Barclays Global Healthcare Conference at 9:00 a.m. ET on Wednesday, March 15, 2023 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About\u00a0Regeneron Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and &hellip; Continue reading \"Regeneron Announces Investor Conference Presentations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-31T21:04:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron Announces Investor Conference Presentations","datePublished":"2023-01-31T21:04:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/","name":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=","datePublished":"2023-01-31T21:04:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDAwMSM1Mzg0MDE0IzIwMDYyNTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-11\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron Announces Investor Conference Presentations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727329"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727329\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}